Logo image of MRD.CA

MELCOR DEVELOPMENTS LTD (MRD.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:MRD - CA5854671032 - Common Stock

15.4 CAD
0 (0%)
Last: 1/12/2026, 7:00:00 PM
Fundamental Rating

6

MRD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 34 industry peers in the Real Estate Management & Development industry. MRD has an excellent financial health rating, but there are some minor concerns on its profitability. MRD scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, MRD could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

MRD had positive earnings in the past year.
MRD had a positive operating cash flow in the past year.
In the past 5 years MRD has always been profitable.
Each year in the past 5 years MRD had a positive operating cash flow.
MRD.CA Yearly Net Income VS EBIT VS OCF VS FCFMRD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

With a decent Return On Assets value of 2.85%, MRD is doing good in the industry, outperforming 67.65% of the companies in the same industry.
MRD has a Return On Equity (4.72%) which is in line with its industry peers.
MRD has a Return On Invested Capital of 5.50%. This is in the better half of the industry: MRD outperforms 76.47% of its industry peers.
MRD had an Average Return On Invested Capital over the past 3 years of 3.82%. This is significantly below the industry average of 10.66%.
The 3 year average ROIC (3.82%) for MRD is below the current ROIC(5.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.85%
ROE 4.72%
ROIC 5.5%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
MRD.CA Yearly ROA, ROE, ROICMRD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

1.3 Margins

MRD has a Profit Margin of 14.91%. This is in the better half of the industry: MRD outperforms 64.71% of its industry peers.
MRD's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 38.68%, MRD is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
In the last couple of years the Operating Margin of MRD has grown nicely.
MRD's Gross Margin of 47.83% is in line compared to the rest of the industry. MRD outperforms 58.82% of its industry peers.
MRD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.68%
PM (TTM) 14.91%
GM 47.83%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
MRD.CA Yearly Profit, Operating, Gross MarginsMRD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

MRD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MRD has been reduced compared to 1 year ago.
The number of shares outstanding for MRD has been reduced compared to 5 years ago.
Compared to 1 year ago, MRD has an improved debt to assets ratio.
MRD.CA Yearly Shares OutstandingMRD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MRD.CA Yearly Total Debt VS Total AssetsMRD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

MRD has an Altman-Z score of 1.64. This is a bad value and indicates that MRD is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MRD (1.64) is better than 61.76% of its industry peers.
MRD has a debt to FCF ratio of 5.63. This is a neutral value as MRD would need 5.63 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.63, MRD belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
MRD has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.48, MRD is doing good in the industry, outperforming 61.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 5.63
Altman-Z 1.64
ROIC/WACC0.82
WACC6.7%
MRD.CA Yearly LT Debt VS Equity VS FCFMRD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

MRD has a Current Ratio of 3.44. This indicates that MRD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.44, MRD belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
A Quick Ratio of 3.44 indicates that MRD has no problem at all paying its short term obligations.
MRD's Quick ratio of 3.44 is amongst the best of the industry. MRD outperforms 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 3.44
Quick Ratio 3.44
MRD.CA Yearly Current Assets VS Current LiabilitesMRD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

MRD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 414.41%, which is quite impressive.
The Earnings Per Share has been decreasing by -0.67% on average over the past years.
Looking at the last year, MRD shows a very strong growth in Revenue. The Revenue has grown by 29.55%.
Measured over the past years, MRD shows a quite strong growth in Revenue. The Revenue has been growing by 10.94% on average per year.
EPS 1Y (TTM)414.41%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%140.67%
Revenue 1Y (TTM)29.55%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%21.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRD.CA Yearly Revenue VS EstimatesMRD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
MRD.CA Yearly EPS VS EstimatesMRD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 1 1.5 2

8

4. Valuation

4.1 Price/Earnings Ratio

MRD is valuated reasonably with a Price/Earnings ratio of 8.11.
MRD's Price/Earnings ratio is rather cheap when compared to the industry. MRD is cheaper than 82.35% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.25, MRD is valued rather cheaply.
A Price/Forward Earnings ratio of 7.66 indicates a rather cheap valuation of MRD.
Based on the Price/Forward Earnings ratio, MRD is valued cheaply inside the industry as 97.06% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.98. MRD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.11
Fwd PE 7.66
MRD.CA Price Earnings VS Forward Price EarningsMRD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MRD indicates a rather cheap valuation: MRD is cheaper than 94.12% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, MRD is valued cheaply inside the industry as 97.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.39
EV/EBITDA 6.36
MRD.CA Per share dataMRD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of MRD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

MRD has a Yearly Dividend Yield of 3.42%.
Compared to an average industry Dividend Yield of 2.18, MRD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.92, MRD pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.42%

5.2 History

The dividend of MRD decreases each year by -2.57%.
MRD has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-2.57%
Div Incr Years0
Div Non Decr Years0
MRD.CA Yearly Dividends per shareMRD.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

23.67% of the earnings are spent on dividend by MRD. This is a low number and sustainable payout ratio.
The Dividend Rate of MRD has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP23.67%
EPS Next 2YN/A
EPS Next 3YN/A
MRD.CA Yearly Income VS Free CF VS DividendMRD.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M
MRD.CA Dividend Payout.MRD.CA Dividend Payout, showing the Payout Ratio.MRD.CA Dividend Payout.PayoutRetained Earnings

MELCOR DEVELOPMENTS LTD

TSX:MRD (1/12/2026, 7:00:00 PM)

15.4

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-06 2025-11-06
Earnings (Next)03-11 2026-03-11
Inst Owners8.8%
Inst Owner ChangeN/A
Ins Owners14.24%
Ins Owner ChangeN/A
Market Cap462.77M
Revenue(TTM)393.96M
Net Income(TTM)58.75M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.42%
Yearly Dividend0.44
Dividend Growth(5Y)-2.57%
DP23.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 8.11
Fwd PE 7.66
P/S 1.17
P/FCF 4.39
P/OCF 4.01
P/B 0.37
P/tB 0.37
EV/EBITDA 6.36
EPS(TTM)1.9
EY12.34%
EPS(NY)2.01
Fwd EY13.05%
FCF(TTM)3.51
FCFY22.79%
OCF(TTM)3.84
OCFY24.95%
SpS13.11
BVpS41.46
TBVpS41.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number42.1
Profitability
Industry RankSector Rank
ROA 2.85%
ROE 4.72%
ROCE 7.63%
ROIC 5.5%
ROICexc 5.73%
ROICexgc 5.9%
OM 38.68%
PM (TTM) 14.91%
GM 47.83%
FCFM 26.77%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
ROICexc(3y)3.93%
ROICexc(5y)3.72%
ROICexgc(3y)4.06%
ROICexgc(5y)3.84%
ROCE(3y)5.31%
ROCE(5y)5.03%
ROICexgc growth 3Y4.23%
ROICexgc growth 5Y17.72%
ROICexc growth 3Y4.16%
ROICexc growth 5Y17.7%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
F-Score9
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 5.63
Debt/EBITDA 3.87
Cap/Depr 841.25%
Cap/Sales 2.54%
Interest Coverage 250
Cash Conversion 75.16%
Profit Quality 179.48%
Current Ratio 3.44
Quick Ratio 3.44
Altman-Z 1.64
F-Score9
WACC6.7%
ROIC/WACC0.82
Cap/Depr(3y)1460.36%
Cap/Depr(5y)1587.21%
Cap/Sales(3y)6.3%
Cap/Sales(5y)7.47%
Profit Quality(3y)95.67%
Profit Quality(5y)124.25%
High Growth Momentum
Growth
EPS 1Y (TTM)414.41%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%140.67%
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.55%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%21.9%
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y40.36%
EBIT growth 3Y4.12%
EBIT growth 5Y17.48%
EBIT Next Year-3.66%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y265.25%
FCF growth 3Y18.66%
FCF growth 5Y52.08%
OCF growth 1Y122.64%
OCF growth 3Y10.64%
OCF growth 5Y25.86%

MELCOR DEVELOPMENTS LTD / MRD.CA FAQ

What is the ChartMill fundamental rating of MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MRD.CA.


What is the valuation status for MRD stock?

ChartMill assigns a valuation rating of 8 / 10 to MELCOR DEVELOPMENTS LTD (MRD.CA). This can be considered as Undervalued.


What is the profitability of MRD stock?

MELCOR DEVELOPMENTS LTD (MRD.CA) has a profitability rating of 6 / 10.


What is the valuation of MELCOR DEVELOPMENTS LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MELCOR DEVELOPMENTS LTD (MRD.CA) is 8.11 and the Price/Book (PB) ratio is 0.37.


What is the earnings growth outlook for MELCOR DEVELOPMENTS LTD?

The Earnings per Share (EPS) of MELCOR DEVELOPMENTS LTD (MRD.CA) is expected to decline by -5.24% in the next year.